164 related articles for article (PubMed ID: 12270155)
1. Development of potent and selective dipeptidyl peptidase II inhibitors.
Senten K; Van der Veken P; Bal G; De Meester I; Lambeir AM; Scharpé S; Bauvois B; Haemers A; Augustyns K
Bioorg Med Chem Lett; 2002 Oct; 12(20):2825-8. PubMed ID: 12270155
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and SAR of potent and selective dipeptide-derived inhibitors for dipeptidyl peptidases.
Senten K; Van der Veken P; De Meester I; Lambeir AM; Scharpé S; Haemers A; Augustyns K
J Med Chem; 2003 Nov; 46(23):5005-14. PubMed ID: 14584950
[TBL] [Abstract][Full Text] [Related]
3. Fluoro-olefins as peptidomimetic inhibitors of dipeptidyl peptidases.
Van der Veken P; Senten K; Kertèsz I; De Meester I; Lambeir AM; Maes MB; Scharpé S; Haemers A; Augustyns K
J Med Chem; 2005 Mar; 48(6):1768-80. PubMed ID: 15771423
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and dipeptidyl peptidase inhibition of N-(4-substituted-2,4-diaminobutanoyl)piperidines.
Soroka A; Van der Veken P; De Meester I; Lambeir AM; Maes MB; Scharpé S; Haemers A; Augustyns K
Bioorg Med Chem Lett; 2006 Sep; 16(18):4777-9. PubMed ID: 16844373
[TBL] [Abstract][Full Text] [Related]
5. Glutamic acid analogues as potent dipeptidyl peptidase IV and 8 inhibitors.
Lu IL; Lee SJ; Tsu H; Wu SY; Kao KH; Chien CH; Chang YY; Chen YS; Cheng JH; Chang CN; Chen TW; Chang SP; Chen X; Jiaang WT
Bioorg Med Chem Lett; 2005 Jul; 15(13):3271-5. PubMed ID: 15927466
[TBL] [Abstract][Full Text] [Related]
6. Gamma-amino-substituted analogues of 1-[(S)-2,4-diaminobutanoyl]piperidine as highly potent and selective dipeptidyl peptidase II inhibitors.
Senten K; Van Der Veken P; De Meester I; Lambeir AM; Scharpé S; Haemers A; Augustyns K
J Med Chem; 2004 May; 47(11):2906-16. PubMed ID: 15139769
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo.
Someya Y; Tahara A; Nakano R; Matsuyama-Yokono A; Nagase I; Fukunaga Y; Takasu T; Hayakawa M; Shibasaki M
Naunyn Schmiedebergs Arch Pharmacol; 2008 May; 377(3):209-17. PubMed ID: 18398600
[TBL] [Abstract][Full Text] [Related]
8. 1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino]acetyl-2-(S)-pyrrolidinecarbonitrile: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties.
Villhauer EB; Brinkman JA; Naderi GB; Dunning BE; Mangold BL; Mone MD; Russell ME; Weldon SC; Hughes TE
J Med Chem; 2002 Jun; 45(12):2362-5. PubMed ID: 12036346
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase 8/9-like activity in human leukocytes.
Maes MB; Dubois V; Brandt I; Lambeir AM; Van der Veken P; Augustyns K; Cheng JD; Chen X; Scharpé S; De Meester I
J Leukoc Biol; 2007 May; 81(5):1252-7. PubMed ID: 17287297
[TBL] [Abstract][Full Text] [Related]
10. 2-[3-[2-[(2S)-2-Cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]- 1,2,3,4-tetrahydroisoquinoline: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV.
Tsu H; Chen X; Chen CT; Lee SJ; Chang CN; Kao KH; Coumar MS; Yeh YT; Chien CH; Wang HS; Lin KT; Chang YY; Wu SH; Chen YS; Lu IL; Wu SY; Tsai TY; Chen WC; Hsieh HP; Chao YS; Jiaang WT
J Med Chem; 2006 Jan; 49(1):373-80. PubMed ID: 16392822
[TBL] [Abstract][Full Text] [Related]
11. The discovery of novel 5,6,5- and 5,5,6-tricyclic pyrrolidines as potent and selective DPP-4 inhibitors.
Cox JM; Chu HD; Kuethe JT; Gao YD; Scapin G; Eiermann G; He H; Li X; Lyons KA; Metzger J; Petrov A; Wu JK; Xu S; Sinha-Roy R; Weber AE; Biftu T
Bioorg Med Chem Lett; 2016 Jun; 26(11):2622-6. PubMed ID: 27106708
[TBL] [Abstract][Full Text] [Related]
12. 7-But-2-ynyl-9-(6-methoxy-pyridin-3-yl)-6-piperazin-1-yl-7,9-dihydro-purin-8-one is a novel competitive and selective inhibitor of dipeptidyl peptidase IV with an antihyperglycemic activity.
Yamazaki K; Yasuda N; Inoue T; Nagakura T; Kira K; Shinoda M; Saeki T; Tanaka I
J Pharmacol Exp Ther; 2006 Dec; 319(3):1253-7. PubMed ID: 16980568
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and activity of a potent, specific azabicyclo[3.3.0]-octane-based DPP II inhibitor.
Danilova O; Li B; Szardenings AK; Huber BT; Rosenblum JS
Bioorg Med Chem Lett; 2007 Jan; 17(2):507-10. PubMed ID: 17055271
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9.
Lankas GR; Leiting B; Roy RS; Eiermann GJ; Beconi MG; Biftu T; Chan CC; Edmondson S; Feeney WP; He H; Ippolito DE; Kim D; Lyons KA; Ok HO; Patel RA; Petrov AN; Pryor KA; Qian X; Reigle L; Woods A; Wu JK; Zaller D; Zhang X; Zhu L; Weber AE; Thornberry NA
Diabetes; 2005 Oct; 54(10):2988-94. PubMed ID: 16186403
[TBL] [Abstract][Full Text] [Related]
15. Novel amidino-substituted benzimidazoles: synthesis of compounds and inhibition of dipeptidyl peptidase III.
Agić D; Hranjec M; Jajcanin N; Starcević K; Karminski-Zamola G; Abramić M
Bioorg Chem; 2007 Apr; 35(2):153-69. PubMed ID: 17174378
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: identification of dipeptide derived leads.
Van der Veken P; De Meester I; Dubois V; Soroka A; Van Goethem S; Maes MB; Brandt I; Lambeir AM; Chen X; Haemers A; Scharpé S; Augustyns K
Bioorg Med Chem Lett; 2008 Jul; 18(14):4154-8. PubMed ID: 18556199
[TBL] [Abstract][Full Text] [Related]
17. Design of (omega-N-(O-acyl)hydroxy amid) aminodicarboxylic acid pyrrolidides as potent inhibitors of proline-specific peptidases.
Demuth HU; Schlenzig D; Schierhorn A; Grosche G; Chapot-Chartier MP; Gripon JC
FEBS Lett; 1993 Mar; 320(1):23-7. PubMed ID: 8096464
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of potent 4-fluoro-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors.
Fukushima H; Hiratate A; Takahashi M; Mikami A; Saito-Hori M; Munetomo E; Kitano K; Chonan S; Saito H; Suzuki A; Takaoka Y; Yamamoto K
Bioorg Med Chem; 2008 Apr; 16(7):4093-106. PubMed ID: 18243000
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of xanthine derivatives on dipeptidyl peptidase 4.
Lin K; Cai Z; Wang F; Zhang W; Zhou W
Chem Pharm Bull (Tokyo); 2013; 61(4):477-82. PubMed ID: 23358258
[TBL] [Abstract][Full Text] [Related]
20. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
